Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Thomas Hein

Advertisement

Articles by Thomas Hein

Tablet Innovation: Sizing up the Value

ByThomas Hein
October 6th 2015

Pharmaceutical Executive

The rising focus on difficulties in swallowing tablets spells a big opportunity for pharma.

Advertisement

Latest Updated Articles

  • Tablet Innovation: Sizing up the Value
    Tablet Innovation: Sizing up the Value

    October 6th 2015



Advertisement
Advertisement

Trending on PharmExec

1

The Legacy of Rutledge: How States and Congress Can Still Regulate Pharmacy Benefit Managers

2

FDA Approves Onswik for Adults with Type 2 Diabetes

3

Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset

4

FDA Approves Welireg Plus Lenvima for Previously Treated Adult Patients With ccRCC

5

InnoCare Enters $3.35 Billion Research Collaboration and License Agreement with Eli Lilly

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us